You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 325 Immunotherapy with B cell activating antibody CPI-006 in patients (pts) with mild to moderate COVID-19 stimulates anti-SARS-CoV-2 antibody response, memory B cells and memory T effector cells

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
325 Immunotherapy with B cell activating antibody CPI-006 in patients (pts) with mild to moderate COVID-19 stimulates anti-SARS-CoV-2 antibody response, memory B cells and memory T effector cells

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020266015
Dec 20202405
Jan 20213606
Feb 20213608
Mar 202166011
Apr 20216006
May 20211906
Jun 20211015
Jul 20210015
Aug 2021007
Sep 2021008
Oct 202174024
Nov 202122016
Dec 20212805
Jan 202252010
Feb 202233015
Mar 20222207
Apr 202255011
May 202246012
Jun 20225508
Jul 20222602
Aug 202246011
Sep 202247010
Oct 20223804
Nov 20225407
Dec 20224605
Jan 20231604
Feb 202316016
Mar 20231403
Apr 202340011
May 20232204
Jun 20232203
Jul 20231004
Aug 20232001
Sep 20231803
Oct 20231604
Nov 20233203
Dec 20233602
Jan 202430012
Feb 20243004
Mar 202436023
Apr 20241604
May 20241803
Jun 20242000
Jul 20243002
Aug 20242405
Sep 20243005
Oct 20241805
Nov 20243403
Dec 20241404
Jan 20251607
Feb 2025004
Mar 20250020
Apr 2025009
May 2025003
Jun 2025008
Total17300428